5926 - 5950 of 7939 Results
Title
Year
-
RESTRICTEDTitle: Alpha-synuclein oligomers: a new hopeJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 134Issue #: 6Start Page: 819End Page: 838Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-017-1755-1Best OA location URL: https://europepmc.org/articles/pmc5663814?pdf=renderCitation Count: 255
-
OPENTitle: Cholinergic activity and levodopa‐induced dyskinesia: a multitracer molecular imaging studyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 9Start Page: 632End Page: 639Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.438Best OA location URL: https://doi.org/10.1002/acn3.438Citation Count: 17
-
OPENTitle: LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson’s diseaseJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 26Issue #: 22Start Page: 4340End Page: 4351Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddx320Best OA location URL: https://academic.oup.com/hmg/article-pdf/26/22/4340/24339268/ddx320.pdfCitation Count: 83
-
OPENTitle: Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particlesJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 8Start Page: e0181844End Page: e0181844Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0181844Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0181844&type=printableCitation Count: 28
-
OPENTitle: Measures of impulsivity in Parkinson's disease decrease after DBS in the setting of stable dopamine therapyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 44Issue #:Start Page: 13End Page: 17Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.08.006Best OA location URL: http://www.prd-journal.com/article/S1353802017302870/pdfCitation Count: 22
-
OPENTitle: Beliefs About Use of Complementary Health Approaches for Parkinson's DiseaseJournal Name: Holistic Nursing PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 31Issue #: 5Start Page: 290End Page: 294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/hnp.0000000000000229Best OA location URL: https://europepmc.org/articles/pmc5664950?pdf=renderCitation Count: 0
-
OPENTitle: Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trialJournal Name: The LancetPublisher: Elsevier BVVol: 390Issue #: 10103Start Page: 1664End Page: 1675Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s0140-6736(17)31585-4Best OA location URL: https://europepmc.org/articles/pmc5831666?pdf=renderCitation Count: 603
-
OPENTitle: Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-017-07181-0Best OA location URL: https://www.nature.com/articles/s41598-017-07181-0.pdfCitation Count: 103
-
OPENTitle: BRAPH: A graph theory software for the analysis of brain connectivityJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 8Start Page: e0178798End Page: e0178798Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0178798Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0178798&type=printableCitation Count: 206
-
OPENTitle: Establishing the role of rare coding variants in known Parkinson's disease risk lociJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 59Issue #:Start Page: 220.e11End Page: 220.e18Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2017.07.009Best OA location URL: https://orca.cardiff.ac.uk/id/eprint/109440/1/Establishing%20the%20role%20of%20rare%20coding%20variants%20in%20known%20Parkinson.pdfCitation Count: 17
-
RESTRICTEDTitle: Microglial phenotypes in Parkinson’s disease and animal models of the diseaseJournal Name: Progress in NeurobiologyPublisher: Elsevier BVVol: 155Issue #:Start Page: 57End Page: 75Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pneurobio.2016.04.006Best OA location URL: https://europepmc.org/articles/pmc5073045?pdf=renderCitation Count: 207
-
OPENTitle: mzStudio: A Dynamic Digital Canvas for User-Driven Interrogation of Mass Spectrometry DataJournal Name: ProteomesPublisher: MDPI AGVol: 5Issue #: 3Start Page: 20End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/proteomes5030020Best OA location URL: https://www.mdpi.com/2227-7382/5/3/20/pdf?version=1501590909Citation Count: 22
-
RESTRICTEDTitle: The role of neurotransmitters in the development of Parkinson's disease‐related psychosisJournal Name: European Journal of NeurologyPublisher: WileyVol: 24Issue #: 10Start Page: 1244End Page: 1254Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.13376Citation Count: 48
-
OPENTitle: Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementiaJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-017-0276-4Best OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-017-0276-4Citation Count: 110
-
OPENTitle: Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling AnalysisJournal Name: Clinical and Translational SciencePublisher: WileyVol: 11Issue #: 1Start Page: 63End Page: 70Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/cts.12492Best OA location URL: https://doi.org/10.1111/cts.12492Citation Count: 40
-
OPENTitle: Parkinson disease–associatedLRRK2 G2019Stransgene disrupts marrow myelopoiesis and peripheral Th17 responseJournal Name: Journal of Leukocyte BiologyPublisher: Oxford University Press (OUP)Vol: 102Issue #: 4Start Page: 1093End Page: 1102Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1189/jlb.1a0417-147rrBest OA location URL: https://jlb.onlinelibrary.wiley.com/doi/pdfdirect/10.1189/jlb.1A0417-147RRCitation Count: 29
-
RESTRICTEDTitle: No evidence for toxicity after long-term photobiomodulation in normal non-human primatesJournal Name: Experimental Brain ResearchPublisher: Springer Science and Business Media LLCVol: 235Issue #: 10Start Page: 3081End Page: 3092Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00221-017-5048-7Citation Count: 33
- Impact of Cost-Sharing Increases on Continuity of Specialty Drug Use: A Quasi-Experimental Study2017OPENTitle: Impact of Cost-Sharing Increases on Continuity of Specialty Drug Use: A Quasi-Experimental StudyJournal Name: Health Services ResearchPublisher: WileyVol: 53Issue #: S1Start Page: 2735End Page: 2757Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/1475-6773.12744Best OA location URL: https://europepmc.org/articles/pmc6056595?pdf=renderCitation Count: 23
- A user's guide for α‐synuclein biomarker studies in biological fluids: Perianalytical considerations2017RESTRICTEDTitle: A user's guide for α‐synuclein biomarker studies in biological fluids: Perianalytical considerationsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 8Start Page: 1117End Page: 1130Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27090Best OA location URL: https://europepmc.org/articles/pmc5638072?pdf=renderCitation Count: 55
-
OPENTitle: Motor subtype changes in early Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 43Issue #:Start Page: 67End Page: 72Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.07.018Best OA location URL: https://europepmc.org/articles/pmc5842811?pdf=renderCitation Count: 63
- Vagally mediated effects of brain stem dopamine on gastric tone and phasic contractions of the rat2017OPENTitle: Vagally mediated effects of brain stem dopamine on gastric tone and phasic contractions of the ratJournal Name: American Journal of Physiology-Gastrointestinal and Liver PhysiologyPublisher: American Physiological SocietyVol: 313Issue #: 5Start Page: G434End Page: G441Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/ajpgi.00180.2017Best OA location URL: https://www.physiology.org/doi/pdf/10.1152/ajpgi.00180.2017Citation Count: 20
-
OPENTitle: Evaluating community health workers' attributes, roles, and pathways of action in immigrant communitiesJournal Name: Preventive MedicinePublisher: Elsevier BVVol: 103Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ypmed.2017.07.020Best OA location URL: https://europepmc.org/articles/pmc6354577?pdf=renderCitation Count: 38
- Minimal clinically important difference of the Modified Fatigue Impact Scale in Parkinson's disease2017RESTRICTEDTitle: Minimal clinically important difference of the Modified Fatigue Impact Scale in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 43Issue #:Start Page: 101End Page: 104Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.07.016Citation Count: 17
-
RESTRICTEDTitle: Striatal cholinergic interneurons and Parkinson's diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 47Issue #: 10Start Page: 1148End Page: 1158Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.13638Best OA location URL: https://europepmc.org/articles/pmc6074051?pdf=renderCitation Count: 70
-
OPENTitle: Tissue-specific network-based genome wide study of amygdala imaging phenotypes to identify functional interaction modulesJournal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 33Issue #: 20Start Page: 3250End Page: 3257Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/bioinformatics/btx344Best OA location URL: https://academic.oup.com/bioinformatics/article-pdf/33/20/3250/28016045/btx344.pdfCitation Count: 23